Anti-Cancer Drugs
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Aims and Scope
Anti-Cancer Drugs is an international medical journal, which aims to promote and encourage research on anti-cancer agents. It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities. The journal has 10 issues per year and the current editor in chief is Mels Sluyser. According to the 2014 Journal Citation Reports, the journal has an impact factor of 1.784, ranking it 164th out of 211 in the category Oncology and 162nd out of 254 in the category Pharmacology & Pharmacy. Less
Key Metrics
Journal Specifications
- PublisherLIPPINCOTT WILLIAMS & WILKINS
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1990
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Anti-Cancer Drugs been publishing? 
The Anti-Cancer Drugs has been publishing since 1990 till date.
How frequently is the Anti-Cancer Drugs published?
Anti-Cancer Drugs is published Monthly.
What is the H-index. SNIP score, Citescore and SJR of Anti-Cancer Drugs?
Anti-Cancer Drugs has a H-index score of 98, Citescore of 5.2, SNIP score of 0.52, & SJR of Q3
Who is the publisher of Anti-Cancer Drugs?
The publisher of Anti-Cancer Drugs is LIPPINCOTT WILLIAMS & WILKINS.
Where can I find a journal's aims and scope of Anti-Cancer Drugs?
For the Anti-Cancer Drugs's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Anti-Cancer Drugs on editage?
For the Anti-Cancer Drugs metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Anti-Cancer Drugs?
The eISSN number is 1473-5741 and pISSN number is 0959-4973 for Anti-Cancer Drugs.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Cell growth, Colorectal cancer, Overall survival, Lung cancer, Hepatocellular carcinoma, Vinpocetine, Cisplatin, Cell cycle, Reactive oxygen species, Toxicity, Epidermal growth factor receptor, Squamous cell lung cancer, Hysterectomy, Breast cancer, Autophagy, Polymeric nanoparticles, Glioblastoma, Diffuse large B-cell lymphoma, Western blot, Tyrosine kinase.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.